Literature DB >> 6897345

Activity of ivermectin against canine intestinal helminths.

D L Anderson, E L Roberson.   

Abstract

The anthelmintic activity of ivermectin was tested in 98 dogs against adult ascarids (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, A braziliense), and whipworms (Trichuris vulpis), and against experimentally induced infections (4th-stage larvae) of T canis and A caninum. Dosage levels tested were single subcutaneous injections of 50, 100, 200, or 400 micrograms/kg of body weight with appropriate vehicle-treated controls. A minimum of 4 (usually 5) dogs were tested with each parasite and dosage level. The lowest dosage level, 50 micrograms/kg, and all higher dosage levels expelled greater than 99% of the adult forms of both species of hookworms and intestinal larval forms of A caninum, as determined by worm counts at necropsy. A dosage level of 100 micrograms/kg was required to expel greater than 99% of whipworms and 200 micrograms/kg was necessary to expel adult (91%) and larval (97%) stages of T canis. Ivermectin was only marginally effective (34.2%, 46.2%, 69.2%, and 53.8%) against Toxascaris leonina at 50, 100, 200, and 400 micrograms/kg, respectively, and had no effect against occasional infections with the tapeworms, Dipylidium caninum (14 dogs) and Taenia spp (3 dogs).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897345

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats.

Authors:  N Pagé; C de Jaham; M Paradis
Journal:  Can Vet J       Date:  2000-10       Impact factor: 1.008

2.  A review of the pharmacology and clinical uses of ivermectin.

Authors:  T B Barragry
Journal:  Can Vet J       Date:  1987-08       Impact factor: 1.008

3.  Pharmacokinetic studies of ivermectin: effects of formulation.

Authors:  P K Lo; D W Fink; J B Williams; J Blodinger
Journal:  Vet Res Commun       Date:  1985-09       Impact factor: 2.459

4.  Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.

Authors:  Feli M Walther; Mark J Allan; Rainer K A Roepke
Journal:  Parasit Vectors       Date:  2015-10-06       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.